UH-RA1, UH-RA9, UH-RA14, and UH-RA21 have been identified as four new biomarkers that can help in early diagnosis of rheumatoid arthritis (RA), specifically in one-third of patients who test negative for currently recognized antibodies. MedPage Today reports:
Four new biomarkers have been identified that can help in the early diagnosis of rheumatoid arthritis (RA), particularly among the one-third of patients who test negative for currently recognized autoantibodies, a researcher reported here.
In a cohort of 292 patients, the diagnosis of RA couldn't be confirmed in 34% because tests for rheumatoid factor (RF) and anti-cyclic citrullinated peptides (CCP) were negative, said Liesbeth M. De Winter, who is a PhD student at Hasselt University in Diepenbeek, Belgium.
But that number fell to 24% using a test panel that included the biomarkers UH-RA1, UH-RA9, UH-RA14, and UH-RA21, De Winter explained at the annual meeting of the European League Against Rheumatism (EULAR).
Read the full story here: http://bit.ly/1axh5qn
Certain Patient Groups Continue to Be Underrepresented in PD Studies in the Netherlands
February 4th 2023With greater attention being paid to the heterogenous patient population, researchers questioned whether this has resulted in a more diverse group of patients included in Parkinson disease (PD) studies in the Netherlands.
Read More
Promoting Health Equity and Resiliency in Trauma-Affected Communities
January 31st 2023On this episode of Managed Care Cast, we speak with Reverend Paul Abernathy, CEO of the Neighborhood Resilience Project and board member of UPMC for You, who discusses his experiences in promoting health and resiliency in trauma-affected communities, as well as challenges related to access and accessibility of care and medical mistrust.
Listen
Examining Telehealth Uptake to Increase Equitable Care Access
January 26th 2023To mark the publication of The American Journal of Managed Care®’s 12th annual health IT issue, on this episode of Managed Care Cast, we speak with Christopher M. Whaley, PhD, health care economist at the RAND Corporation, who focuses on health economics issues, including the influence of the COVID-19 pandemic on health care delivery.
Listen
NCCN Launches Pilot Project Aiming to Measure, Implement Health Equity in Cancer Care Practices
February 4th 2023Five leading academic cancer centers are assessing the feasibility of implementing the Health Equity Report Card pilot project as a tool that can both meaningfully and feasibly measure and report on equitable care practices.
Read More
2 Clarke Drive
Cranbury, NJ 08512